Systematic evaluation and reevaluation of Jinghua Weikang in the treat-ment of Helicobacter pylori infection
Objective To evaluate the qualiety of systematic evaluation of of Jinghua Weikang in the treatment of Helicobacter pylori infection.Methods In this study,a systematic review/meta-analysis of Jinghua Weikang in the treatment of Helicobacter pylori infection was conducted by computer retrieval of PubMed,the Cochrane Library,EMbase,CNKI,VIP,China Biomedical Literature Service System,and Wanfang Data.The search period was set from the inception to July 2023.The included studies were assessed for methodological and reporting quality using the AMSTAR 2 and PRISMA 2020 tools,and the quality of evidence was assessed using the GRADE system.Results A systematic review/meta analysis of five articles of Jinghua Weikang in the treatment of Helicobacter pylori infection were included.The results of AMSTAR 2 evaluation showed that all systems were rated as extremely low quality.The score of PRISMA 2020 ranged from 15.5 to 23.0.The results of GRADE evidence classification showed that the overall quality of evidence was low.Conclusion Jinghua Weikang has certain advantages in treating Helicobacter pylori,however,the report quality,methodology quality,and evidence quality of literature are generally low,and more high-quality studies are needed to provide strong evidence support.
Helicobacter pyloriJinghua WeikangOverview of systematic reviewsAMSTAR 2PRISMAGARDE
NETL
NSTL
万方数据
